Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
A Phase I Study of the Safety and Pharmacokinetics of Venetoclax in Paediatric and Young Adult Patients with Relapsed or Refractory Malignancies
Protocol ID
M13-833
Disease (Sub Disease)
Leukaemia (ALL/AML)
Diagnosis Stage
Relapse/ refractory
Location
NSW, QLD, VIC, SA
Sponsor
AbbVie
Collaborators
Roche-Genentech
Trial Status
Open
Sites
Queensland Children's Hospital
Sydney Children's Hospital
Royal Children's Hospital
Women's & Children's Hospital
Study Type
Treatment
Phase
Phase 1
Age Eligibility
up to 25 years
International registry ID's
NCT03236857
Back to Registry
Study Title A Phase I Study of the Safety and Pharmacokinetics of Venetoclax in Paediatric and Young Adult Patients with Relapsed or Refractory Malignancies
Protocol ID M13-833
Disease (Sub Disease) Leukaemia (ALL/AML)
Diagnosis Stage Relapse/ refractory
Location NSW / QLD / VIC / SA
Sponsor AbbVie
Collaborators Roche-Genentech
Links https://clinicaltrials.gov/ct2/show/NCT03236857
Trial Status Open
Trial Open Date 17/08/2017
Sites Queensland Children's Hospital / Sydney Children's Hospital / Royal Children's Hospital / Women's & Children's Hospital
Study Type Treatment
Phase Phase 1
Age Eligibility up to 25 years
International registry ID's NCT03236857